Unique ERalpha cistromes control cell type-specific gene regulation.

Area of Science:

• Endocrinology
• Molecular Biology
• Genomics

Background:

• Estrogens are crucial hormones influencing normal physiology and diseases in tissues like breast and bone.
• The precise mechanisms behind estrogen's cell type- and disease-specific actions remain unclear.
• Understanding these mechanisms is vital for targeted therapies and disease management.

Purpose of the Study:

• To investigate the molecular basis of cell type-specific gene regulation by estrogen.
• To compare estrogen receptor alpha (ERalpha) binding and gene expression patterns in different cell types.
• To elucidate the role of transcription factors and epigenetic modifications in mediating cell-specific estrogen responses.

Main Methods:

• Gene expression profiling using expression microarrays in MCF7 (breast cancer) and U2OS-ERalpha (osteoblast-like) cells.
• Chromatin immunoprecipitation followed by genomic tiling arrays (ChIP-on-chip) to map ERalpha binding sites.
• Analysis of transcription factor binding motifs (e.g., FoxA1) and epigenetic histone modifications.

Main Results:

• Fewer than 10% of 17beta-estradiol (E2)-regulated genes were common between MCF7 and U2OS-ERalpha cells.
• The majority of ERalpha binding sites were cell type-specific, correlating with distinct gene expression patterns.
• The transcription factor FoxA1, crucial in MCF7 cells, was absent in U2OS-ERalpha cells, impacting ERalpha binding.
• ERalpha binding sites (cistromes) correlated with cell type-specific epigenetic histone modifications.

Conclusions:

• Estrogen's cell type-specific effects are primarily driven by distinct ERalpha binding to specific regulatory regions.
• Epigenetic modifications and cell-specific transcription factor availability significantly shape the ERalpha cistrome.
• This provides a framework for understanding how estrogen mediates diverse cellular responses.